D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$820M |
| 2 |
Visa
V
|
+$667M |
| 3 |
HES
Hess
HES
|
+$515M |
| 4 |
Mastercard
MA
|
+$425M |
| 5 |
Oracle
ORCL
|
+$382M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Advanced Micro Devices
AMD
|
+$949M |
| 3 |
Citigroup
C
|
+$419M |
| 4 |
ExxonMobil
XOM
|
+$391M |
| 5 |
Booking.com
BKNG
|
+$349M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 40.59% |
| 2 | Technology | 18.36% |
| 3 | Consumer Discretionary | 9.46% |
| 4 | Financials | 6.95% |
| 5 | Healthcare | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
COOP
2301
DELISTED
Mr. Cooper
COOP
| $2.58M | ﹤0.01% |
33,100
-3,700
| -10% | -$258K |
|
2302
Meritage Homes
MTH
$4.12B
| $2.57M | ﹤0.01% |
29,348
+26,728
| +1,020% | +$2.16M |
|
|
WCLD
2303
WisdomTree Cloud Computing Fund
WCLD
$323M
| $2.57M | ﹤0.01% |
+73,930
| New | +$2.58M |
|
2304
Xperi
XPER
$268M
| $2.57M | ﹤0.01% |
213,006
+27,473
| +15% | +$302K |
|
2305
PUT
Dave & Buster's
PLAY
$234M
| $2.57M | ﹤0.01% |
41,000
-27,400
| -40% | -$1.57M |
|
2306
CALL
Biogen
BIIB
$31.8B
| $2.57M | ﹤0.01% |
+11,900
| New | +$2.79M |
|
2307
PUT
Axcelis
ACLS
$3.38B
| $2.56M | ﹤0.01% |
23,000
-11,100
| -33% | -$1.32M |
|
2308
Cytokinetics
CYTK
$9.56B
| $2.56M | ﹤0.01% |
+36,554
| New | +$2.83M |
|
|
PMT
2309
PennyMac Mortgage Investment
PMT
$767M
| $2.56M | ﹤0.01% |
174,188
+67,241
| +63% | +$961K |
|
2310
Omega Healthcare
OHI
$14.1B
| $2.56M | ﹤0.01% |
80,730
-13,649
| -14% | -$415K |
|
2311
CALL
Skywest
SKYW
$3.74B
| $2.56M | ﹤0.01% |
37,000
-50,000
| -57% | -$2.96M |
|
2312
CALL
Carrier Global
CARR
$44.4B
| $2.55M | ﹤0.01% |
43,900
-268,300
| -86% | -$15.1M |
|
|
NBIS
2313
Nebius Group N.V.
NBIS
$60.8B
| $2.55M | ﹤0.01% |
170,002
-19,100
| -10% | -$287K |
|
2314
ESAB
ESAB
$4.04B
| $2.55M | ﹤0.01% |
23,031
-56,405
| -71% | -$5.27M |
|
2315
CALL
Iron Mountain
IRM
$34B
| $2.54M | ﹤0.01% |
31,700
-232,800
| -88% | -$16.8M |
|
2316
CALL
Floor & Decor
FND
$5.03B
| $2.54M | ﹤0.01% |
+19,600
| New | +$2.23M |
|
2317
Restaurant Brands International
QSR
$25.4B
| $2.53M | ﹤0.01% |
31,849
-3,911
| -11% | -$305K |
|
2318
Tandem Diabetes Care
TNDM
$1.17B
| $2.53M | ﹤0.01% |
71,432
-21,708
| -23% | -$582K |
|
2319
CALL
Appian
APPN
$2.69B
| $2.53M | ﹤0.01% |
63,300
| – | – |
|
2320
ZipRecruiter
ZIP
$304M
| $2.52M | ﹤0.01% |
219,706
-143,418
| -39% | -$1.93M |
|
2321
PUT
Mobileye
MBLY
$6.82B
| $2.52M | ﹤0.01% |
+78,500
| New | +$2.23M |
|
2322
Ironwood Pharmaceuticals
IRWD
$720M
| $2.51M | ﹤0.01% |
288,653
+59,623
| +26% | +$723K |
|
2323
PUT
Axsome Therapeutics
AXSM
$10.9B
| $2.51M | ﹤0.01% |
+31,500
| New | +$2.64M |
|
2324
Backblaze
BLZE
$815M
| $2.51M | ﹤0.01% |
245,581
+190,788
| +348% | +$1.76M |
|
2325
CALL
AMN Healthcare
AMN
$1.33B
| $2.5M | ﹤0.01% |
40,000
| – | – |
|
Similar funds
D.E. Shaw & Co's Q1 2024 Portfolio in Review
As of Q1 2024, D.E. Shaw & Co held 4,923 positions worth $117B, up 2.1% from $114B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co's Q1 2024 filing shows 655 new, 1,367 increased, 1,722 reduced and 634 closed positions. Its largest new stake was Arm: 2,379,839 shares worth $297M. The largest sale was NVIDIA, an estimated $1.03B.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
- D.E. Shaw & Co's largest Q1 2024 buy was Arm: 2,379,839 shares worth $297M.
- D.E. Shaw & Co added most to Apple in Q1 2024, an estimated $820M increase.
- D.E. Shaw & Co's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.03B.
- D.E. Shaw & Co fully exited iShares JPMorgan USD Emerging Markets Bond ETF in Q1 2024, selling an estimated $307M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $117B portfolio in Q1 2024.
- D.E. Shaw & Co opened 655 new positions and closed 634 in Q1 2024.
- D.E. Shaw & Co's portfolio value rose 2.1% quarter-over-quarter to $117B.
Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.